9 January 2021 12:00 am
The disposable device uses micro-needles to both administer the vaccine and monitor its efficacy by measuring the body’s immune response. Swansea University researchers hope a prototype will be developed by March for clinical trials and aim to make it commercially available within three years.
Source : BBC